Future Proof Health Limited
Unaudited Financial Statements
For the year ended 31 August 2023
Pages for Filing with Registrar
Company Registration No. 09185062 (England and Wales)
Future Proof Health Limited
Company Information
Directors
Dr K Dawes
Mrs B Wakelam
Dr S Pritchard
Dr G Love
Company number
09185062
Registered office
175 The Ridgeway Surgery
Dudley
West Midlands
England
DY3 3UH
Accountants
Moore Kingston Smith LLP
Orbital House
20 Eastern Road
Romford
Essex
RM1 3PJ
Future Proof Health Limited
Contents
Page
Balance sheet
1
Notes to the financial statements
2 - 4
Future Proof Health Limited
Balance Sheet
As at 31 August 2023
Page 1
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
3
Current assets
Debtors
4
39,220
70,061
Cash at bank and in hand
63,711
88,583
102,931
158,644
Creditors: amounts falling due within one year
5
(87,759)
(169,966)
Net current assets/(liabilities)
15,172
(11,322)
Capital and reserves
Called up share capital
6
170,933
170,933
Profit and loss reserves
(155,761)
(182,255)
Total equity
15,172
(11,322)
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 31 August 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 12 March 2024 and are signed on its behalf by:
Mrs B Wakelam
Director
Company Registration No. 09185062
Future Proof Health Limited
Notes to the Financial Statements
For the year ended 31 August 2023
Page 2
1
Accounting policies
Company information
Future Proof Health Limited is a private company limited by shares incorporated in England and Wales. The registered office is 175 The Ridgeway Surgery, Dudley, West Midlands, England, DY3 3UH.
1.1
Accounting convention
These financial statements have been prepared in accordance with Section 1A of FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
At the balance sheet date the company had net assets of £15,172 (2022: net liabilities £11,322) following a profit for the year at £26,494 (2022: loss £44,948). At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future and for a period of at least twelve months following the approval of these financial statements. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements. true
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for health care services provided in the normal course of business.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Computer equipment
25% straight line
1.5
Cash and cash equivalents
Cash at bank and in hand are basic financial assets and include cash in hand and deposits held at call with banks.
1.6
Financial instruments
All of the company's financial assets and liabilities are basic and measured at amortised cost.
Future Proof Health Limited
Notes to the Financial Statements (Continued)
For the year ended 31 August 2023
Page 3
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was 13 (2022: 13)
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 September 2022 and 31 August 2023
1,399
Depreciation and impairment
At 1 September 2022 and 31 August 2023
1,399
Carrying amount
At 31 August 2023
At 31 August 2022
4
Debtors
2023
2022
Amounts falling due within one year:
£
£
Other debtors
664
-
Prepayments and accrued income
38,556
70,061
39,220
70,061
5
Creditors: amounts falling due within one year
2023
2022
£
£
Taxation and social security
1,925
23,894
Other creditors
2,193
867
Accruals and deferred income
83,641
145,205
87,759
169,966
Future Proof Health Limited
Notes to the Financial Statements (Continued)
For the year ended 31 August 2023
Page 4
6
Called up share capital
2023
2022
£
£
Ordinary share capital
47 Ordinary A shares of 1p each
1
1
310,785 Ordinary B shares of 55p each
170,932
170,932
170,933
170,933
The 47 ordinary 'A' shares with a nominal value of 1p each carry voting rights but no dividend rights.
The 310,785 ordinary 'B' shares with a nominal value of 55p each carry no voting rights but have full dividend rights.
On winding up the 'A' shares carry preferential rights to a distribution.
7
Related party transactions
During the year consultancy services were charged by the directors of £27,750 (2022: £27,750). Included in other creditors are amounts due to the directors of £14,300 (2022: £14,150).